Evidence map›Paper›PMID 33846547›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2021

Clinicopathologic and molecular analysis of embryonal rhabdomyosarcoma of the genitourinary tract: evidence for a distinct DICER1-associated subgroup.

Felix K F Kommoss, Damian Stichel, Jaume Mora, Manel Esteller, David T W Jones, Stefan M Pfister, Eva Brack, Marco Wachtel, Peter Karl Bode, Hans-Peter Sinn and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
8.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Clinicopathologic and Molecular Genetic Features of Spindle Cell Rhabdomyosarcoma Harboring ZFP64::NCOA2/3 Fusions: A Series of 14 Cases.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Rhabdomyosarcoma in children and young adults.Virchows Archiv : an international journal of pathology · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 3 countries.

Felix K F KommossInstitute of Pathology, Department of General Pathology, Heidelberg University Hospital, Heidelberg, Germany. felix.kommoss@med.uni-heidelberg.de.ORCID 0000-0003-0876-9087
Damian StichelDepartment of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
Jaume MoraDepartment of Pediatric Onco‑Hematology and Developmental Tumor Biology Laboratory, Hospital Sant Joan de Déu, Barcelona, Catalonia, Spain.
Manel EstellerJosep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain.
David T W JonesHopp Children's Cancer Center (KiTZ), Heidelberg, Germany.ORCID 0000-0002-2036-5141
Stefan M PfisterHopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
Eva BrackDivision of Pediatric Hematology/Oncology, Department of Pediatrics, Inselspital, Bern University Hospital, Bern, Switzerland.
Marco WachtelDepartment of Oncology and Children's Research Center, University Children's Hospital, Zurich, Switzerland.
Peter Karl BodeInstitute of Pathology and Molecular Pathology, University Hospital Zurich (USZ), Zurich, Switzerland.ORCID 0000-0002-9633-4042
Hans-Peter SinnInstitute of Pathology, Department of General Pathology, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0003-2836-6699
Dietmar SchmidtMVZ für Histologie, Zytologie und molekulare Diagnostik Trier GmbH, Trier, Germany.
Thomas MentzelDermatopathologie Bodensee, Friedrichshafen, Germany.
Friedrich KommossInstitute of Pathology, Medizin Campus Bodensee, Friedrichshafen, Germany.
Felix SahmHopp Children's Cancer Center (KiTZ), Heidelberg, Germany.ORCID 0000-0001-5441-1962
Andreas von Deimling *Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany. andreas.vondeimling@med.uni-heidelberg.de.ORCID 0000-0002-5863-540X
Christian Koelsche *Institute of Pathology, Department of General Pathology, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0001-8763-8864
German Cancer Research Center · DEHeidelberg University · DEInstitució Catalana de Recerca i Estudis Avançats · ESDermatopathologie Friedrichshafen · DEHospital Sant Joan de Déu Barcelona · ESMedizin Campus Bodensee · DEUniversity Hospital of Bern · CHUniversity Hospital of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Embryonal rhabdomyosarcoma (ERMS) of the uterus has recently been shown to frequently harbor DICER1 mutations. Interestingly, only rare cases of extrauterine DICER1-associated ERMS, mostly located in the genitourinary tract, have been reported to date. Our goal was to study clinicopathologic and molecular profiles of DICER1-mutant (DICER1-mut) and DICER1-wild type (DICER1-wt) ERMS in a cohort of genitourinary tumors. We collected a cohort of 17 ERMS including nine uterine (four uterine corpus and five cervix), one vaginal, and seven urinary tract tumors. DNA sequencing revealed mutations of DICER1 in 9/9 uterine ERMS. All other ERMS of our cohort were DICER1-wt. The median age at diagnosis of patients with DICER1-mut and DICER1-wt ERMS was 36 years and 5 years, respectively. Limited follow-up data (available for 15/17 patients) suggested that DICER1-mut ERMS might show a less aggressive clinical course than DICER1-wt ERMS. Histological features only observed in DICER1-mut ERMS were cartilaginous nodules (6/9 DICER1-mut ERMS), in one case accompanied by foci of ossification. Recurrent mutations identified in both DICER1-mut and DICER1-wt ERMS affected KRAS, NRAS, and TP53. Copy number analysis revealed similar structural variations with frequent gains on chromosomes 2, 3, and 8, independent of DICER1 mutation status. Unsupervised hierarchical clustering of array-based whole-genome DNA methylation data of our study cohort together with an extended methylation data set including different RMS subtypes from genitourinary and extra-genitourinary locations (n = 102), revealed a distinct cluster for DICER1-mut ERMS. Such tumors clearly segregated from the clusters of DICER1-wt ERMS, alveolar RMS, and MYOD1-mutant spindle cell and sclerosing RMS. Only one tumor, previously diagnosed as ERMS arising in the maxilla of a 6-year-old boy clustered with DICER1-mut ERMS of the uterus. Subsequent sequencing analysis identified two DICER1 mutations in the latter case. Our results suggest that DICER1-mut ERMS might qualify as a distinct subtype in future classifications of RMS.

Indexed as

AdolescentAdultAgedChildChild, PreschoolDEAD-box RNA HelicasesFemaleHumansInfantMaleMutationRhabdomyosarcoma, EmbryonalRibonuclease IIIUrogenital NeoplasmsYoung AdultDEAD-box RNA HelicasesDICER1 protein, humanRibonuclease III

Identifiers

PMID33846547
PMCPMC8295035
OpenAlexW3155506375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.